TNF and inflammatory bowel disease: In cases of moderate or severe disease, IBD physicians can rely on anti-tumor necrosis factor alfa (anti-TNFα), anti-integrins, anti-interleukin 23 (anti-IL23), and Janus kinase inhibitors (anti-JAK) [10,11].